John Maraganore, Alnylam CEO (Scott Eisen/Bloomberg via Getty Images)
October 28, 2021 02:52 PM EDT
People

'I want to be a grand­dad': Why John Maraganore left and where he (and Al­ny­lam) are go­ing

Jason Mast

Editor

John Maraganore knew that peo­ple would be sur­prised when Al­ny­lam an­nounced his de­par­ture this morn­ing af­ter 19 years as CEO of the com­pa­ny. But …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times